Hsu Che-Fang, Chen Pao-Chu, Seenan Vaishnavi, Ding Dah-Ching, Chu Tang-Yuan
Center for Prevention and Therapy of Gynecological Cancers, Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.
Department of Obstetrics & Gynecology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.
Cancers (Basel). 2021 Jan 26;13(3):468. doi: 10.3390/cancers13030468.
: High-grade serous carcinoma (HGSC) is mainly derived from the stepwise accumulation of driver mutations in the fallopian tube epithelium (FTE), and it subsequently metastasizes to the ovary and peritoneum that develops into a clinically evident ovarian carcinoma. The developmental process involves cell proliferation/clonal expansion, cell migration, anoikis resistance, anchorage-independent growth (AIG), peritoneum attachment, and cell invasion. Previously, we discovered FTE could be transformed by follicular fluid (FF) released from ovulation, the most crucial risk factor of ovarian cancer, and IGF axis proteins in FF confers stemness activation and clonal expansion via IGF-1R/AKT pathway. However, whether other phenotypes in advanced cancer development are involved is unknown. : A panel of FTE and ovarian HGSC cell lines with different severity of transformation were treated with FF with or without IGF-1R and AKT inhibitors and analyzed for the transformation phenotypes in vitro, ex vivo, and in vivo. : FF largely promotes (by order of magnitude) cell migration, AIG, cell invasion, peritoneum attachment, anoikis resistance, and cell proliferation. Most of these activities worked in the full panel of cell lines. The AIG activity largely depends on IGF-1R/AKT phosphorylation, and the proliferation activity depends on an AKT phosphorylation not mediated by IGF-1R. In contrast, both AKT- and non-AKT-mediated signals are responsible for the other transformation activities. : Our data demonstrate an extensive transformation activity of FF in the full journey of carcinogenesis, and endorsed ovulation-inhibition for the prevention and AKT-inhibition for the treatment of ovarian HGSC.
高级别浆液性癌(HGSC)主要源于输卵管上皮(FTE)中驱动突变的逐步积累,随后转移至卵巢和腹膜,发展为临床可见的卵巢癌。其发展过程涉及细胞增殖/克隆扩增、细胞迁移、失巢凋亡抗性、非锚定依赖性生长(AIG)、腹膜附着和细胞侵袭。此前,我们发现FTE可被排卵释放的卵泡液(FF)转化,卵泡液是卵巢癌最关键的危险因素,卵泡液中的IGF轴蛋白通过IGF-1R/AKT途径赋予干性激活和克隆扩增能力。然而,尚不清楚晚期癌症发展中的其他表型是否参与其中。
用含或不含IGF-1R和AKT抑制剂的卵泡液处理一组具有不同转化严重程度的FTE和卵巢HGSC细胞系,并在体外、离体和体内分析其转化表型。
卵泡液在很大程度上促进(按数量级)细胞迁移、AIG、细胞侵袭、腹膜附着、失巢凋亡抗性和细胞增殖。这些活动大多在所有细胞系中起作用。AIG活性很大程度上取决于IGF-1R/AKT磷酸化,而增殖活性取决于不由IGF-1R介导的AKT磷酸化。相比之下,AKT介导和非AKT介导的信号均负责其他转化活动。
我们的数据证明了卵泡液在致癌作用全过程中具有广泛的转化活性,并支持通过抑制排卵预防卵巢HGSC以及通过抑制AKT治疗卵巢HGSC。